A 46-year-old male asked:
can sandostatin (octreotide) lar be used as treatment of elevated 5-hiaa in aggressive type of systemic mastocytosis? thank you. (repeated question)
1 doctor answer
Dr. Le Wang answered
35 years experience Internal Medicine
Possibly: Possibly for symtomatic management. However, malignant GI diseases can be mistaken for systemic mastocytosis. Whereas 5HIAA is elevated in carcinoid syndrome, it usually is normal in SM. Aggressive systemic mastocytosis usually requires chemotherapy or imatinib.
Answered on Jan 11, 2015
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more. Get help now:
People also searched for:
Connect by text or video with a U.S. board-certified doctor now — wait time is less than 1 minute!